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Abstract
Background Patients with resectable hilar cholangiocar-
cinoma often present obstructive jaundice and a small
future remnant liver (FRL) ratio. A sequential approach
comprising preoperative biliary drainage followed by por-
tal vein embolization (PVE) is usually performed but leads
to long preoperative management (6–12 weeks) before
patients can undergo resection. To simplify and shorten this
phase of liver preparation, we developed a new preopera-
tive approach that involves percutaneous biliary drainage
and PVE during the same procedure. We report the out-
comes of this combined procedure.
Methods During 1 year, four patients underwent simul-
taneous biliary drainage and PVE followed 1 month later
by surgical resection of hilar cholangiocarcinoma. Liver
volumes were assessed by CT before, and 1, and 3 months
after the combined procedure. Serum liver enzymes were
assessed before and 1 month after the combined procedure.
Results The combined procedure was feasible in all cases,
with no related complications. After the combined proce-
dure, transaminases remained stable or decreased, whereas
gamma-glutamyl-transpeptidase, alkaline phosphatase, and
bilirubin decreased. During the first month, the left lobe
volume increased by ?27.9 % (range 19–40.9 %). The FRL
ratio increased from 24.9 to 33.2 %. All patients underwent
R0 liver resection with a favorable postoperative outcome.
The remnant liver volume increased by ?132 % (range
78–245 %) between 1 and 3 months.
Conclusions Simultaneous percutaneous biliary drainage
and PVE is feasible. This all-in-one preoperative approach
greatly decreases waiting time until surgical resection.
These encouraging results warrant further investigation to
confirm the safety and to evaluate the reduction in the
dropout rate for liver resection in this tumor with poor
prognosis.
Keywords Portal vein  Embolization  Biliary tract 
Drainage  Bile obstruction  Liver regeneration
Introduction
Surgery for hilar cholangiocarcinoma is a complex proce-
dure usually requiring extended hepatectomy, resection of
the caudate lobe, extrahepatic bile duct resection, and bil-
iary-enteric anastomosis. In-hospital mortality after hepatic
resection is usually higher than 10 % (up to 21 %) in
patients with obstructive jaundice, whereas it is 8 % in
cirrhotic patients and only 1 % in patients with normal
liver [1, 2]. Biliary obstruction can result in bacterial
translocation, hemostasis impairment, malnutrition, renal
insufficiency, and an increased risk of postoperative liver
dysfunction [3, 4]. In this context, major surgical resection
is risky and most surgical teams recommend performing
preoperative biliary drainage [5–8].
The future remnant liver (FRL) volume is another
challenge to bring the patient to surgery because it often
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is insufficient given the large volume of resected liver in
extended hepatectomy for hilar cholangiocarcinoma. In
this setting, it is generally accepted that there is a high
risk of postoperative hepatic failure when the FRL vol-
ume is lower than 40 % [4, 5, 9]. Portal vein emboliza-
tion (PVE) has been proposed to increase the functional
reserve of the remnant liver [10–12]. The usual approach
is first to drain the biliary tree of the FRL until bilirubin
has fallen below 5 mg/dl and then to perform contralat-
eral PVE. However, this preoperative management takes
time before the patient can be resected. Indeed, it usually
takes more than 4 weeks for the jaundice to resolve [5]
and an additional 4 weeks to obtain sufficient liver
regeneration after the PVE. During this period, tumor
progression may occur thereby precluding any curative
treatment.
To simplify and shorten this phase of liver preparation,
we developed a combined preoperative approach in which
percutaneous biliary drainage and PVE are performed
during the same procedure. The aim of this study is to
report the outcomes of this combined approach used in four
patients with hilar cholangiocarcinoma.
Materials and Methods
This study consisted of a retrospective analysis of our
experience with combined biliary drainage and portal vein
embolization performed during the same procedure before
surgical resection of hilar cholangiocarcinoma. All patients
gave their written informed consent for the procedure and
our institutional review board approved the retrospective
analysis of their data.
During a 1-year period, 12 patients were referred to our
department for percutaneous biliary drainage for hilar
cholangiocarcinoma that was either histologically proven
or highly suspected on baseline imaging data. Among
them, four patients were considered eligible for surgical
resection but required a preoperative PVE procedure,
because the planned resection would have left less than
40 % of functional liver parenchyma estimated by CT liver
volumetry. The therapeutic strategy was discussed at our
weekly liver tumor board meeting, including liver sur-
geons, oncologists, hepatologists, and interventional radi-
ologists. These four patients were considered for a
combined (biliary drainage ? PVE) procedure and thus
were included in this retrospective study. Three men (age
range: 57–71 years) and one woman (age: 57 years) had
hilar cholangiocarcinoma classified as Bismuth-Corlette
stage II (n = 1) and IIIA (n = 3). None of the patients had
liver cirrhosis or had undergone prior therapy, such as
systemic chemotherapy. No patient had clinical signs of
sepsis or cholangitis.
Technique
Combined biliary drainage and PVE were performed under
general anesthesia (Fig. 1). All patients received
Fig. 1 Axial CT scan (A) in a 71-year old patient showing biliary
obstruction due to hilar cholangiocarcinoma (Bismuth-Corlette IIIa).
Puncture of the portal venous system just after internal–external
biliary drainage of the FRL (B). Portography before (C) and after
(D) PVE using NBCA. Axial CT scan (E) performed 3 weeks later,
showing hypertrophy of the left lobe (19 % increase). Axial CT scan
(F) performed 2 months after extended hepatectomy showing major
hypertrophy of the remnant liver (78 % increase)
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intravenous prophylactic antibiotics (ceftriaxone). For bil-
iary access, we used a ‘‘1-stick’’ technique [13] using a
Neff introducer set (Cook Medical, Bloomington, IN).
First, the left bile ducts (preferentially a segment III
branch) were punctured under US guidance with a 15-cm-
long, 21-gauge Chiba introducer needle and opacified.
Then, a 0.018-inch Cope mandril guidewire was introduced
through the needle to gain initial access. Finally, the tri-
axial dilator and sheath combination was introduced over
the micro-guidewire allowing accommodation of a 0.035-
inch guidewire in the outer sheath after removal of the
inner dilator and sheath. A 11-cm-long, 8F sheath (Super
Arrow Flex PSI set, Teleflex Medicine, Athlone, Ireland)
was inserted into the bile ducts to secure access and
facilitate the passage of a 5F shaped catheter (Soft-vu
Berenstein, AngioDynamics, Cambridge, UK) and a stiff
hydrophilic 0.035-inch guidewire (Terumo, Tokyo, Japan)
used to cross the biliary obstruction and ultimately gain
access to the duodenum. Then, a 0.035-inch, 80-cm Am-
platz extra-stiff wire (Cook Medical) was inserted to allow
the passage of an 8.5F internal-external drainage catheter
(Mac-Loc, Cook Medical), positioned so that the side holes
would drain the left intrahepatic ducts and the ‘‘pigtail’’
configuration of the distal end of the catheter will be placed
into the duodenum. If the primary biliary drainage was
technically successful with no evidence of hemobilia, the
PVE procedure was performed immediately thereafter.
Under US guidance, a left portal vein branch (prefer-
entially the portal branch corresponding to the bile duct
punctured for biliary drainage) was accessed using the
same type of instruments as for the biliary access
(21-gauge Chiba needle, Neff introducer set). If the US
examination was obscured by artifacts resulting from the
biliary procedure, the portal vein branch was punctured
under fluoroscopic guidance, close to the previously
punctured bile duct. A 5F shaped catheter (Soft-vu Ber-
enstein) was advanced over a 0.035-inch hydrophilic
guidewire (Terumo, Tokyo, Japan) into the portal trunk
where portography was performed. The PVE procedure
was performed as described elsewhere [11, 14]; the right
second-order portal branches were selectively catheterized
one by one using the shaped catheter and then embolized
with boluses of 0.5 ml of a mixture of Lipiodol and
n-butyl-cyanoacrylate (Histoacryl, B Braun, Tuttlingen,
Germany) after checking that the flow was hepatopetal (a
mixture of 1 ml of n-butyl cyanoacrylate with 1–3 ml of
iodized oil was used). Segment IV was not embolized.
Following embolization, the shaped catheter was carefully
flushed into the right portal branch with 5 % glucose
solution and then repositioned in the portal trunk, where
post-PVE portography was performed. During the 2 days
following the procedure, pain was managed using mor-
phine titration when necessary.
Volumetric CT Assessment and Outcome Evaluation
Baseline computed tomography (CT) imaging data were
obtained a mean 12 (range: 1–26) days before the com-
bined procedure, and follow-up imaging was performed
approximately 1 month (mean: 26 days; range: 22–33
days) and 3 months (mean: 92 days; range: 80–105 days)
after the combined procedure. CT images with a 2.5-mm
slice thickness were obtained during the portal phase (70 s
after injection of 100 cc of 350 mg/ml iodine at 3 cc/s)
after injection of contrast media with a 64-detector row
Lightspeed multislice CT unit (General Electric, Milwau-
kee, WI). On each image, the whole liver and the left lobe
(segments II and III) were delineated with a hand-held
cursor and their respective volumes were automatically
calculated by the workstation (Advantage windows, Gen-
eral Electric). The ratio between the left lobe volume and
the whole liver volume was then calculated and defined as
the FRL ratio.
Liver Enzymes
Serum liver enzymes were assessed by measuring serum
aspartate aminotransferase (AST), serum alanine amino-
transferase (ALT), gamma-glutamyl-transpeptidase (GGT),
alkaline phosphatase (ALP), prothrombin time (PT), and
total bilirubin levels before and 1 month after the com-
bined procedure.
Statistical Analysis
Categorical variables were described using percentages.
The levels of liver enzymes and liver volumes were
expressed as means and standard deviations. Given the low
statistical power due to the small number of patients,
comparisons of laboratory tests and liver volumes were not
performed. All descriptive analyses were performed using
Stata software version 11.0 (Stata Corporation, College
Station, TX).
Results
The mean baseline bilirubin level was 136 lmol/l (stan-
dard deviation: 114). The combined procedure (biliary
drainage ? PVE) was feasible in all cases. No complica-
tions related to the procedure occurred. After the combined
procedure, AST and ALT remained stable or decreased,
whereas GGT, ALP, and bilirubin decreased and PT tended
to decrease (Table 1).
Regarding liver volumes during the first month
(Table 2), the left lobe (segment II ? III) increased in size
from 550 to 692 ml (mean increase: 27.9 %), whereas total
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liver volume decreased from 2,178 to 2,046 ml (mean
decrease: 6 %). The FRL ratio increased from 24.9 to
33.2 %, leading to an 8.3 % increase. Patients were oper-
ated on the day following the CT-scan evaluation at
1 month. All patients underwent R0 right hepatectomy
extended to segment IV and I, which pathological exami-
nation confirmed the diagnosis of hilar cholangiocarci-
noma. The mean duration of the surgical procedure was
398 (range: 324–445) min. The mean transfusion require-
ments were 1.75 (range: 0–4) units, and the mean patient
stay in an intensive care unit was 4 (range: 0–9) days.
Postoperatively, patient #2 developed a fistula from the
biliary-enteric anastomosis which was managed conserva-
tively. Patient #3 developed a wound infection, and patient
#4 had a biloma drained percutaneously without sub-
sequent biliary fistula. All of the patients had favorable
postoperative outcomes (mean hospital stay: 18 days;
range: 11–28 days). At 3 months, the mean remnant liver
volume was 1,565 ml, leading to a ?132 % mean increase
(range: 78–245 %) between 1 and 3 months (Fig. 2).
Discussion
To our knowledge, this is the first report of such a strategy
for the management of resectable hilar cholangiocarci-
noma. This technique was successfully applied in our four
patients with no related complications, thereby demon-
strating its feasibility. In Klatskin tumors, liver resection is
the only treatment that allows prolonged survival. Surgery
is considered high risk, because it removes for oncologic
reasons not only a hemiliver (generally right) but also
segments IV and I and requires biliary-enteric anastomosis.
Most patients present with obstructive jaundice and a small
FRL ratio. In order to avoid postoperative liver failure, a
sequential approach that consists of preoperative biliary
drainage followed by portal vein embolization is usually
performed [3, 5, 6, 9, 15–19]. Biliary drainage (preferen-
tially internal [8, 9, 20]) is performed to relieve the jaun-
dice and thereby prevent cholangitis, multiorgan failure,
and impaired hepatic regeneration after surgery [3, 4].
However after biliary drainage, 4 to 6 weeks are needed to
reach a bilirubin level below 2–5 mg/dl (34–85 lmol/l)
[5, 9, 18, 21, 22] before patients can benefit from PVE. An
additional 2–6 weeks is then necessary after PVE to induce
a sufficient functional increase in the FRL. Therefore, this
approach usually leads to a long preoperative management
(6–12 weeks) before patients undergo resection. In a large
series of 494 patients managed by biliary drainage fol-
lowed by PVE, 25 % did not undergo subsequent hepa-
tectomy due to disease progression during the preoperative
period [17]. We therefore developed an aggressive preop-
erative approach by combining biliary drainage and PVET
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during the same procedure, to decrease the delay before
surgery and to simplify the preoperative management.
The incidence of tumor seeding along the biliary drain
tract has been reported as high as 5.2 % and is related to
the duration of drainage (the risk of tract recurrence was
3.16 times higher when biliary drainage lasted [60 days)
[23]. Reducing the duration of biliary drainage therefore
also may reduce the risk of tumor seeding.
Cholestasis has been shown to impair hepatic regener-
ative capacity [24]. The portal triad (portal vein, hepatic
artery, and bile duct) is limited to a small anatomic space
(the so-called Mall’s space), because it is surrounded by the
connective tissue sheath of the Glisson capsule [24, 25]. In
cases of biliary dilatation, portal vessels are compressed
significantly due to their low intravascular pressure (com-
pared with hepatic arteries). This results in decreased portal
venous flow and thus impairs hepatic regeneration and
hypertrophy after PVE [24, 26]. Interestingly, biliary
drainage quickly decreases pressure in bile ducts and thus
subsequent portal compression [27], whereas PVE signifi-
cantly increases the portal flow velocity, which correlates
with liver hypertrophy. It has even been reported that PVE
could relieve persistent jaundice despite complete biliary
drainage by inducing functional enhancement of the
nonembolized liver [28]. In a model of cholestatic rat liver
[29], the activity of DNA polymerase as a marker of
hepatocyte proliferation significantly increased after portal
vein ligation whether biliary decompression was performed
before or at the same time as portal vein ligation.
Finally, many investigators reported that cholestasis
alters the metabolic function of hepatocytes, especially
mitochondrial respiratory function [7, 28, 29]. Internal
biliary drainage slowly improves mitochondrial activity
[15, 20], but interestingly, PVE has been shown to increase
mitochondrial enzymatic activities as quickly as 2 days
after the procedure [30]. All of this strongly suggests that
early PVE might benefit icteric patients [29].
After the combined procedure, liver enzymes showed
similar evolution to that observed after biliary drainage
alone [21]. Indeed, bilirubin level exhibited a marked
decrease, as did ALP and GGT [21]. Of note, the relatively
low baseline level of bilirubin testifies to the fact that
jaundice was probably not long-lasting in our patients.
ALT and AST remained stable or decreased, as it is usually
observed after PVE alone. When comparing liver volumes
during the first month, FLR volume exhibited a mean
increase of 27.9 % resulting in an 8.3 % increase of the
FLR ratio (FRL/total liver volume). As previously reported
[11], it is difficult to compare volume increases with those
in other series because of differences regarding: (1) the
embolizing agents used, (2) case mixes of liver tumors, (3)
time to volumetric assessment, and (4) methods to measure
FRL hypertrophy. Although different embolizing materials
were used in published series reporting on biliary drainage
followed by PVE, volumetric results seem similar. In 189
patients, Nagino et al. [16] reported a 27.4 % increase in
FRL volume and a 10 % increase in FRL ratio. In another
study, Hong et al. [19] reported a 27.2 % increase in FRL
volume with a 7.3 % increase in FRL ratio. However, in a
very recent study, the same technique (with same embolic
material) applied in noncholestatic livers resulted in a 74 %
increase in FRL volume [11]. This could fit with less
effective PVE in cholestatic livers. But interestingly, a
significant increase in total liver volume has been reported
in rat models due to liver swelling in cases of biliary
obstruction [31, 32]. Thus, our measurements took into
Table 2 Liver volumes before and 1 month after the combined procedure
Patient # FRL volume (ml) Total liver volume Ratio of FRL (%)
Before At 1 month % increase Before At 1 month Before At 1 month % increase
1 386 511 32.4 1,750 1,620 22.1 31.5 9.4
2 424 504 19 2,336 1,998 18.1 25.2 7.1
3 930 1,108 19.1 2,373 2,376 39.1 46.6 7.5
4 459 647 40.9 2,251 2,190 20.4 29.5 9.1
Mean ± SD 550 ± 255 692 ± 285 27.9 ± 10.7 2,178 ± 290 2,046 ± 323 24.9 ± 9.6 33.2 ± 9.3 8.3 ± 1.1
Fig. 2 Changes in volumes of segment II ? III for 3 months after the
combined procedure (patients were operated on at 1 month)
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account not only volumetric changes related to PVE (i.e.,
increase) but also those related to biliary drainage (i.e.,
decrease). This can explain why total liver volume
decreased in our four patients, whereas it did not vary in
the studies by Nagino et al. and Hong et al. [16, 19]. More
importantly and for the same reason, it also is likely that
FRL hypertrophy was underestimated in our four patients
compared with the preceding studies. After major hepa-
tectomy, liver remnant volumes usually increase from 30 to
50 % during the first 3–6 months [33, 34]. Surprisingly, the
volume increase in the left lobe (segment II ? III) was
much greater between 1 and 3 months (?132 %), thereby
demonstrating the excellent regenerative ability of the liver
1 month after the combined procedure.
Indocyanine green clearance of the FRL or galactosyl
human serum albumin scintigraphy are more appropriate
methods than liver volumetry to assess the gain in liver
function [9]. In addition, these techniques also could be very
helpful to determine the optimal waiting time for liver
regeneration after the combined procedure. Unfortunately,
because of the retrospective design, neither measurement
was available in our study. In patients with jaundice due to
biliary tract cancer, it has been reported that FRL hypertro-
phy could be observed as early as 11 days after PVE [15].
Whether or not the synergistic effects of combined biliary
drainage and PVE are confirmed, it would be possible to
reduce the waiting time before surgery to less than 4 weeks.
Conclusions
Despite the small number of patients, we have demon-
strated the feasibility of concomitant biliary drainage and
PVE. It is not reasonable to perform this procedure in cases
of sepsis, cholangitis, or if any complications are encoun-
tered during the biliary drainage. This all-in-one preoper-
ative approach strongly decreases waiting time until
surgical resection, thereby reducing the risk of cancer
progression and the risk of tumor seeding along the biliary
drain tract. These encouraging results warrant further
investigations to confirm the safety of this procedure and to
evaluate the reduction in the dropout rate for liver resection
in this tumor with poor prognosis. FRL hypertrophy seems
comparable to that reported after the classic sequential
approach and is probably underestimated. Further studies
that evaluate liver function more precisely could demon-
strate a synergistic effect of PVE combined with biliary
drainage and determine the optimal delay before resection.
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